Luspatercept | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Luspatercept
Health Canada Patents

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Luspatercept

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

2 API Suppliers, 2 NDC API

2 API Suppliers
2 NDC API

DEVELOPMENTS

40 Drugs in Development

40 Drugs in Development

FINISHED DOSAGE FORMULATIONS

4 FDF Dossiers, 2 FDA Orange Book, 2 Canada

4 FDF Dossiers
2 FDA Orange Book
2 Canada

DIGITAL CONTENT

59 News #PharmaBuzz

59 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 8 Annual Reports

1 US Medicaid Prescriptions
8 Annual Reports

MARKET PLACE

1 FDF Dossiers

1 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 Health Canada Patents

8 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

8 All

01 8McCarthy Tétrault

filter Patent Reset all filters

8 All

01 22574777

02 22672758

03 22677160

04 22733911

filter Product Reset all filters

8 All

01 8LUSPATERCEPT

filter Dosage Reset all filters

8 All

01 8POWDER FOR SOLUTION

filter Exp Date Reset all filters

8 All

01 22025-07-25

02 22027-12-18

03 22028-02-04

04 22029-08-13

Product Main Page

01

McCarthy Tétrault

LUSPATERCEPT

ChemOutsourcing

Not Confirmed

McCarthy Tétrault

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-07-25

Date Granted : 2015-09-01

LUSPATERCEPT

Brand Name : REBLOZYL

Patent Number : 2574777

Filing Date : 2005-07-25

Strength per Unit : 25 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2025-07-25

Date Granted : 2015-09-01

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

McCarthy Tétrault

LUSPATERCEPT

ChemOutsourcing

Not Confirmed

McCarthy Tétrault

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-12-18

Date Granted : 2019-07-30

LUSPATERCEPT

Brand Name : REBLOZYL

Patent Number : 2672758

Filing Date : 2007-12-18

Strength per Unit : 25 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2027-12-18

Date Granted : 2019-07-30

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

McCarthy Tétrault

LUSPATERCEPT

ChemOutsourcing

Not Confirmed

McCarthy Tétrault

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-02-04

Date Granted : 2019-05-21

LUSPATERCEPT

Brand Name : REBLOZYL

Patent Number : 2677160

Filing Date : 2008-02-04

Strength per Unit : 25 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2028-02-04

Date Granted : 2019-05-21

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

McCarthy Tétrault

LUSPATERCEPT

ChemOutsourcing

Not Confirmed

McCarthy Tétrault

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-08-13

Date Granted : 2019-09-03

LUSPATERCEPT

Brand Name : REBLOZYL

Patent Number : 2733911

Filing Date : 2009-08-13

Strength per Unit : 25 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2029-08-13

Date Granted : 2019-09-03

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

McCarthy Tétrault

LUSPATERCEPT

ChemOutsourcing

Not Confirmed

McCarthy Tétrault

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-07-25

Date Granted : 2015-09-01

LUSPATERCEPT

Brand Name : REBLOZYL

Patent Number : 2574777

Filing Date : 2005-07-25

Strength per Unit : 75 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2025-07-25

Date Granted : 2015-09-01

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

McCarthy Tétrault

LUSPATERCEPT

ChemOutsourcing

Not Confirmed

McCarthy Tétrault

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-12-18

Date Granted : 2019-07-30

LUSPATERCEPT

Brand Name : REBLOZYL

Patent Number : 2672758

Filing Date : 2007-12-18

Strength per Unit : 75 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2027-12-18

Date Granted : 2019-07-30

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

McCarthy Tétrault

LUSPATERCEPT

ChemOutsourcing

Not Confirmed

McCarthy Tétrault

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-02-04

Date Granted : 2019-05-21

LUSPATERCEPT

Brand Name : REBLOZYL

Patent Number : 2677160

Filing Date : 2008-02-04

Strength per Unit : 75 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2028-02-04

Date Granted : 2019-05-21

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

McCarthy Tétrault

LUSPATERCEPT

ChemOutsourcing

Not Confirmed

McCarthy Tétrault

Country

ChemOutsourcing

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-08-13

Date Granted : 2019-09-03

LUSPATERCEPT

Brand Name : REBLOZYL

Patent Number : 2733911

Filing Date : 2009-08-13

Strength per Unit : 75 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2029-08-13

Date Granted : 2019-09-03

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!